- Moderna’s Stock Plummets After Cancer-Vaccine Data Shared on Social Media WSJ
- Moderna Stock Sinks Nearly 20% After Leak of Cancer-Vaccine Data Investopedia
- Experimental mRNA vaccine cuts risk melanoma returns by 42% CNN
- Cancer Vaccine Cuts the Risk of Melanoma Recurrence, Drug Makers Report The New York Times
- Moderna sheds about $24 billion as cancer vaccine data triggers ‘sell-the-news’ retreat Reuters
